E. Jennifer Edelman, MD, MHS, BS
Professor of Medicine (General Medicine)Cards
About
Research
Publications
2024
Reasons for declining participation in inpatient research among historically minoritized racial and ethnic communities: A scoping review
Bavishi P, Grimshaw A, Perez O, Kiluk B, Edelman E. Reasons for declining participation in inpatient research among historically minoritized racial and ethnic communities: A scoping review. Contemporary Clinical Trials Communications 2024, 42: 101386. DOI: 10.1016/j.conctc.2024.101386.Peer-Reviewed Original ResearchStudy burdenInpatient hospital settingSocial support networksSocial support systemsPhysician involvementScoping reviewRecruitment methodsInpatient settingPatient trustWeb of Science databasesDeclined participationRefusing participationEquitable recruitmentEthnicity dataHospital settingSupport networksRecruitment effortsRefusal reasonsInpatient stayStudy designInclusion criteriaEnhance participationDemographic informationCochrane LibraryClinical trialsGuideline concordance of electronic health record order sets for hospital‐based treatment of alcohol withdrawal syndrome
Cohen S, Kashyap N, Steel T, Edelman E, Fiellin D, Joudrey P. Guideline concordance of electronic health record order sets for hospital‐based treatment of alcohol withdrawal syndrome. Journal Of Hospital Medicine 2024 PMID: 39580659, DOI: 10.1002/jhm.13556.Peer-Reviewed Original ResearchElectronic health recordsElectronic health record ordersTreatment of alcohol withdrawal syndromeSevere alcohol withdrawal syndromeTreatment of unhealthy alcohol useAlcohol withdrawal syndromeUnhealthy alcohol useAcute care hospitalsHospital organizationCross-sectional studyHospital-based treatmentCare practicesHealth recordsCare escalationGuideline concordanceSymptom assessmentCare hospitalProtocolized careRecord ordersAlcohol use disorderSymptom scoresAlcohol useSubstance useHospitalInconsistent definitionsCost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder
Lu T, Ryan D, Cadet T, Chawarski M, Coupet E, Edelman E, Hawk K, Huntley K, Jalali A, O'Connor P, Owens P, Martel S, Fiellin D, D'Onofrio G, Murphy S. Cost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder. Annals Of Emergency Medicine 2024 PMID: 39570250, DOI: 10.1016/j.annemergmed.2024.10.001.Peer-Reviewed Original ResearchHealth care sector perspectiveImplementation facilitatorsOpioid use disorder careIncremental cost-effectiveness ratioCost-effectiveness ratioHealth care sector costsEducational strategiesImplementation facilitation strategyCost-effectiveness acceptability curvesLikelihood of cost-effectivenessCost-effectiveOpioid use disorderQuality-adjusted life yearsUse disorderPatient engagementAcademic EDED visitsAcceptability curvesStandard educationEmergency departmentLife yearsFacilitation strategiesMeasures of effectivenessHealthBuprenorphineAn Urgent Need to Promote Equitable Buprenorphine Administration for Opioid Use Disorder in the Emergency Department.
Coupet E, Edelman E. An Urgent Need to Promote Equitable Buprenorphine Administration for Opioid Use Disorder in the Emergency Department. Journal Of Addiction Medicine 2024 PMID: 39514893, DOI: 10.1097/adm.0000000000001409.Peer-Reviewed Original ResearchBuprenorphine administrationOpioid use disorder treatmentOpioid use disorderUse disorderAddiction treatmentDisorder treatmentEmergency departmentED patientsCross-sectional study of ED patientsTreatment accessBuprenorphineStudy of ED patientsOpioidOpioid overdose deathsOpioid misuseOverdose deathsCross-sectional studyLatinosAddictionPromoting Race and Ethnic Diversity in a Hospital-Based Randomized Clinical Trial to Address Untreated Alcohol Use Disorder: Initial Lessons Learned.
Edelman E, Frankforter T, Rojas-Perez O, Ablondi K, Castro C, Corvino J, Garcia I, Gordon D, Jaramillo Y, Johnson N, Jordan A, Nich C, Paris M, Pagano D, Weimer M, Williams E, Kiluk B. Promoting Race and Ethnic Diversity in a Hospital-Based Randomized Clinical Trial to Address Untreated Alcohol Use Disorder: Initial Lessons Learned. Journal Of Addiction Medicine 2024 PMID: 39514895, DOI: 10.1097/adm.0000000000001400.Peer-Reviewed Original ResearchAlcohol use disorderBrief Negotiation InterviewUntreated alcohol use disorderUse disorderSocial determinants of healthCognitive behavioral therapyElectronic medical record dataDeterminants of healthEthnically diverse sampleMedical record dataMonths of recruitmentBehavioral therapyModifications-EnhancedReporting AdaptationsTreatment engagementEffectiveness of strategiesSocial determinantsInitiation of medicationRecruitment approachesDiverse samplePost-hospitalizationAlcohol useResearch staffParent trialRecord dataClinician and Practice Characteristics Associated With Support of Office-Based Methadone: Findings From a National Survey.
Sung M, Black A, Blevins D, Henry B, Cates-Wessel K, Dawes M, Hagle H, Joudrey P, Molfenter T, Levin F, Fiellin D, Edelman E. Clinician and Practice Characteristics Associated With Support of Office-Based Methadone: Findings From a National Survey. Journal Of Addiction Medicine 2024 PMID: 39475119, DOI: 10.1097/adm.0000000000001388.Peer-Reviewed Original ResearchOpioid use disorderCharacteristics associated with supportTreatment of opioid use disorderMultivariate logistic regression modelOffice-based settingSequential multivariable logistic regression modelsOpioid treatment programsLogistic regression modelsAcademic medical centerUse disorderInclusion criteriaMethadoneMedical CenterPatientsOffice-basedCOVID-19 surveyClinician supportPractice characteristicsLongitudinal treatmentImplementation barriersPolicy changesMOUDOutcome variablesImprove accessNational surveyThe Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol
Womack J, Leblanc M, Sager A, Zaets L, Maisto S, Garcia A, Aoun-Barakat L, Brown S, Edelman E, Fiellin D, Fisher J, Fraenkel L, Kidwai-Khan F, Marconi V, Martino S, Pulk R, Satre D, Virata M, Justice A, Hsieh E. The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol. AIDS And Behavior 2024, 1-15. PMID: 39465468, DOI: 10.1007/s10461-024-04533-6.Peer-Reviewed Original ResearchUnhealthy alcohol useAlcohol usePharmacist-delivered interventionVeterans Aging Cohort StudyPilot study protocolStudy protocolElectronic health recordsSupport behavior changePre-test/post-test designAging Cohort StudySelf-administered surveyAlcohol use disorderAlcohol Research CenterBothersome symptomsPre-test/post-testCommunicating riskHealth recordsLong-term medicationHealth symptomsCounseling interventionCounseling sessionsSessions 2 weeksQualitative interviewsAlcohol consumptionUse disorderIntegrated stepped alcohol treatment with contingency management for unhealthy alcohol use among people with HIV: A randomized controlled trial.
Edelman E, Dziura J, Deng Y, DePhilippis D, Ferguson T, Brown S, Marconi V, Goetz M, Rodriguez-Barradas M, Simberkoff M, Molina P, Weintrob A, Maisto S, Paris M, Justice A, Bryant K, Fiellin D. Integrated stepped alcohol treatment with contingency management for unhealthy alcohol use among people with HIV: A randomized controlled trial. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2024 PMID: 39321757, DOI: 10.1097/qai.0000000000003534.Peer-Reviewed Original ResearchUnhealthy alcohol useSelf-reported abstinenceAlcohol useLost to follow-upContingency managementAlcohol use disorderRandomized controlled trialsSubstance use treatmentAlcohol abstinenceFollow-upUse disorderControlled trialsPWHAlcohol treatmentAbstinenceUse treatmentEvidence of abstinenceHIVWeeksMean proportionTreatmentTrialsAlcoholDaysParticipantsPain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV
Miller E, McGinnis K, Edelman E, Feinberg T, Gordon K, Kerns R, Marshall B, Patterson J, McRae M. Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV. AIDS And Behavior 2024, 28: 3994-4004. PMID: 39264485, PMCID: PMC11586311, DOI: 10.1007/s10461-024-04494-w.Peer-Reviewed Original ResearchMental health classesSubstance use disordersOpioid use disorderHIV statusBuprenorphine initiationVeterans Aging Cohort StudyInitiate buprenorphineMental health diagnosesAging Cohort StudyBuprenorphine treatmentMultiple pain conditionsAssociated with HIV statusInfluence treatment retentionUse disorderTreatment of opioid use disorderHigher comorbidity burdenAge of patientsClinical encountersMental healthHealth diagnosisBlack veteransHealth classesLatent class analysisCohort studyPrescription dataA call to address penicillin allergy labels in patients with hematopoietic stem cell transplants: How to avoid rash decisions
Belmont A, Stone C, Guyer A, Edelman E, Trubiano J. A call to address penicillin allergy labels in patients with hematopoietic stem cell transplants: How to avoid rash decisions. Transplant Infectious Disease 2024, 26: e14350. PMID: 39101669, PMCID: PMC11502247, DOI: 10.1111/tid.14350.Peer-Reviewed Original ResearchHematopoietic stem cell transplantationStem cell transplantationPenicillin allergy labelMultidrug-resistant infectionsPenicillin allergyCell transplantationAllergy labelsAssociated with more severe infectionsReported penicillin allergyRisk-stratify patientsMore severe infectionsPoint-of-care assessmentBeta-lactam antibioticsClinical decision toolTolerate penicillinsAssociated with useDelabel patientsTherapeutic optionsEvaluating patientsSevere infectionsAlternative antibioticsOral challengeClinical care settingsClostridium difficilePatients
Clinical Trials
Current Trials
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE)
HIC ID2000030586RolePrincipal InvestigatorPrimary Completion Date02/28/2023Recruiting ParticipantsGenderBothAge18+ years
Academic Achievements & Community Involvement
Clinical Care
Overview
E. Jennifer Edelman, MD, MHS, specializes in HIV and addiction medicine. She provides patient care for HIV/AIDS and its associated complications, such as HIV-associated myopathy, dementia, and neurocognitive disorder.
In addition to her clinical work in HIV care, Dr. Edelman’s research examines substance use disorder treatment in HIV clinics, emergency department-initiated buprenorphine programs, and alcohol reduction interventions for people with HIV.
A recipient of the New England Society of General Internal Medicine Award for Excellence in Clinical Investigation and the Society of General Internal Medicine Lawrence Linn Award, her research has been supported by grants from the National Institutes of Health, the National Institute on Alcohol Abuse and Alcoholism, and the National Cancer Institute.
Dr. Edelman is a professor of medicine at Yale School of Medicine.
Clinical Specialties
Internal Medicine; Addiction Medicine; HIV & AIDs Medicine
Fact Sheets
Opioid Use Disorder
Learn More on Yale MedicineHuman Immunodeficiency Virus (HIV)
Learn More on Yale MedicineSmoking and Cancer
Learn More on Yale MedicineStimulant Use Disorder
Learn More on Yale Medicine
Board Certifications
Addiction Medicine (Internal Medicine)
- Certification Organization
- AB of Addiction Medicine
- Latest Certification Date
- 2024
- Original Certification Date
- 2014
HIV Specialist
- Certification Organization
- American Academy of HIV Medicine
- Latest Certification Date
- 2021
- Original Certification Date
- 2013
Yale Medicine News
News
News
- December 02, 2024
2025 YCCI Funding Opportunities Open for Applications
- October 23, 2024
Penicillin Allergies Among Patients Undergoing Hematopoietic Stem Cell Transplants
- August 05, 2024
Yale partnership seeks to improve HIV prevention and treatment training in Tbilisi, Georgia
- May 27, 2024
Unhealthy Alcohol Use Among Men who have Sex with Men Taking PrEP for HIV Prevention